Form 4 filings across 4 companies. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$9.2M
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 12 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 24 most recent Form 4 transactions.
| Jun 16 | LQDA | Liquidia Corp | AGRANT | 5,882 | — | — | +1.3% | Open the original filing on SEC.gov |
| Jun 4 | LQDA | Liquidia Corp | SSELL | 12,610 | $64.42 | $812.3K | -1.6% | Open the original filing on SEC.gov |
| Jun 4 | LQDA | Liquidia Corp | SSELL | 68,265 | $63.83 | $4.4M | -7.8% | Open the original filing on SEC.gov |
| Jun 4 | LQDA | Liquidia Corp | SSELL | 19,125 | $62.62 | $1.2M | -2.1% | Open the original filing on SEC.gov |
| Jun 4 | LQDA | Liquidia Corp | SSELL | 88,487 | $64.28 | $5.7M | -11.0% | Open the original filing on SEC.gov |
| Jun 4 | LQDA | Liquidia Corp | SSELL | 11,513 | $63.13 | $726.8K | -1.4% | Open the original filing on SEC.gov |
| Mar 31 | CADL | Candel Therapeutics, Inc. | AGRANT◆ | 4,618 | $4.11 | $19K | — | Open the original filing on SEC.gov |
| Feb 23 | CADL | Candel Therapeutics, Inc. | PBUY | 550,458 | $5.45 | $3M | +24.9% | Open the original filing on SEC.gov |
| Feb 11 | LQDA | Liquidia Corp | JOTHER | 55,116 | $42.63 | $2.3M | +13.3% | Open the original filing on SEC.gov |
| Feb 11 | LQDA | Liquidia Corp | JOTHER | 55,116 | $42.63 | $2.3M | -100.0% | Open the original filing on SEC.gov |
| Nov 25, 2025 | VRCA | Verrica Pharmaceuticals… | PDBUY◆ | 687,690 | — | — | — | Open the original filing on SEC.gov |
| Nov 25, 2025 | VRCA | Verrica Pharmaceuticals… | PDBUY◆ | 343,845 | — | — | — | Open the original filing on SEC.gov |
| Nov 25, 2025 | VRCA | Verrica Pharmaceuticals… | PBUY | 2.8M | $4.24 | $11.7M | +460.3% | Open the original filing on SEC.gov |
| Nov 25, 2025 | VRCA | Verrica Pharmaceuticals… | PBUY | 1.4M | $4.24 | $5.8M | +53.3% | Open the original filing on SEC.gov |
| Sep 2, 2025 | LQDA | Liquidia Corp | SSELL | 74,230 | $29.14 | $2.2M | -14.7% | Open the original filing on SEC.gov |
| Sep 2, 2025 | LQDA | Liquidia Corp | SSELL | 254,038 | $28.67 | $7.3M | -33.5% | Open the original filing on SEC.gov |
| Aug 29, 2025 | LQDA | Liquidia Corp | SSELL | 188,232 | $27.62 | $5.2M | -19.9% | Open the original filing on SEC.gov |
| Aug 28, 2025 | LQDA | Liquidia Corp | SSELL | 154,337 | $27.94 | $4.3M | -14.0% | Open the original filing on SEC.gov |
| Jun 25, 2025 | CADL | Candel Therapeutics, Inc. | AGRANT | 1.1M | $4.67 | $5M | +93.7% | Open the original filing on SEC.gov |
| Jun 17, 2025 | CADL | Candel Therapeutics, Inc. | AGRANT◆ | 14,240 | — | — | — | Open the original filing on SEC.gov |
| Jun 17, 2025 | LQDA | Liquidia Corp | AGRANT | 18,396 | — | — | +90.4% | Open the original filing on SEC.gov |
| May 30, 2025 | TSHA | Taysha Gene Therapies,… | PBUY | 750,000 | $2.75 | $2.1M | +35.9% | Open the original filing on SEC.gov |